Log In
Print this Print this

Listeria monocytogenes/PSA (Lm-LLO-PSA) vaccine (ADXS-PSA) (formerly ADXS31-142)

Also known as: formerly Lovaxin P

  Manage Alerts
Collapse Summary General Information
Company Advaxis Inc.
DescriptionLive attenuated Listeria monocytogenes immunotherapy targeting prostate-specific antigen (KLK3; PSA)
Molecular Target Prostate-specific antigen (KLK3) (PSA)
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationProstate cancer
Indication DetailsTreat metastatic castration-resistant prostate cancer (CRPC); Treat prostate cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today